- Home
- NRBO vs STIM Comparison
NRBO vs STIM Comparison
Compare NRBO & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRBO
- STIM
- Stock Information
- Founded
- NRBO N/A
- STIM 2003
- Country
- NRBO United States
- STIM United States
- Employees
- NRBO N/A
- STIM N/A
- Industry
- NRBO Biotechnology: Pharmaceutical Preparations
- STIM Medical/Dental Instruments
- Sector
- NRBO Health Care
- STIM Health Care
- Exchange
- NRBO Nasdaq
- STIM Nasdaq
- Market Cap
- NRBO 27.9M
- STIM 29.4M
- IPO Year
- NRBO N/A
- STIM 2018
- Fundamental
- Price
- NRBO $2.36
- STIM $0.88
- Analyst Decision
- NRBO Strong Buy
- STIM Buy
- Analyst Count
- NRBO 1
- STIM 4
- Target Price
- NRBO $10.00
- STIM $4.67
- AVG Volume (30 Days)
- NRBO 36.9K
- STIM 801.0K
- Earning Date
- NRBO 11-07-2024
- STIM 11-12-2024
- Dividend Yield
- NRBO N/A
- STIM N/A
- EPS Growth
- NRBO N/A
- STIM N/A
- EPS
- NRBO N/A
- STIM N/A
- Revenue
- NRBO N/A
- STIM $72,711,000.00
- Revenue This Year
- NRBO N/A
- STIM $11.40
- Revenue Next Year
- NRBO N/A
- STIM $12.09
- P/E Ratio
- NRBO N/A
- STIM N/A
- Revenue Growth
- NRBO N/A
- STIM 5.03
- 52 Week Low
- NRBO $2.08
- STIM $0.52
- 52 Week High
- NRBO $6.75
- STIM $5.07
- Technical
- Relative Strength Index (RSI)
- NRBO 40.83
- STIM 46.75
- Support Level
- NRBO $2.30
- STIM $0.67
- Resistance Level
- NRBO $2.50
- STIM $0.82
- Average True Range (ATR)
- NRBO 0.23
- STIM 0.13
- MACD
- NRBO -0.01
- STIM -0.02
- Stochastic Oscillator
- NRBO 24.75
- STIM 47.07
About NRBO NeuroBo Pharmaceuticals Inc.
NeuroBo Pharmaceuticals Inc is a clinical-stage biotechnology company focused predominantly on developing and commercializing novel pharmaceuticals to treat cardiometabolic diseases. The company has two primary programs focused on the treatment of metabolic dysfunction-associated steatohepatitis (MASH), and obesity. Its product pipeline includes DA-1241 which is a novel G-Protein-Coupled Receptor 119 (GPR119) and DA-1726 which is a novel oxyntomodulin (OXM) analog. The company also has four legacy therapeutics programs designed to impact a range of indications in viral, neurodegenerative, and cardiometabolic diseases: ANA001, NB-01, NB-02, and Gemcabene.
About STIM Neuronetics Inc.
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.